Germany sees omicron dominant soon, pushes on vaccination

A senior official says that the omicron variant could be dominant in Germany in one to three weeks

Via AP news wire
Wednesday 22 December 2021 12:46
Virus Outbreak Germany
Virus Outbreak Germany

The omicron variant could be dominant in Germany in one to three weeks, a senior official said Wednesday, while the health minister called for vaccination centers to be kept open over the Christmas holidays to keep the country's booster campaign up to speed.

The European Union s most populous nation has seen about 540 confirmed and 1,848 suspected cases of COVID-19 infections with omicron so far, said Lothar Wieler, the head of the Robert Koch Institute But he noted that those cases are one to two weeks old, because of the time need to report and sequence cases.

“The trend is crystal-clear," Wieler said. "With a doubling time (for cases) of about three days, the new variant could in the next one, two, at the latest three weeks already account for the majority of all infections in our country.”

Omicron is already the dominant form of the coronavirus in England, Scotland and the United States In Germany, a wave of infections caused by the still-dominant delta variant is receding slowly, but officials say the case level is still much too high.

Germany’s federal and state governments agreed on Tuesday to introduce new restrictions by Dec. 28, limiting private gatherings to 10 people, shutting night clubs and removing spectators from major events.

Wieler called for caution before that. He said that Christmas “should not be the spark that sets off the omicron fire” and urged Germans to meet as few people as possible. And he called for people to refrain from unnecessary travel.

German officials say they're confident of fulfilling a pledge from last month to administer 30 million vaccine shots by the end of the year, and aim to get another 30 million shots in arms by the end of January.

Over the holiday period, “I'm asking for vaccination centers to be kept open, I'm asking for (doctors') practices to be used as vaccination centers,” Health Minister Karl Lauterbach said. “I think we have a unique opportunity here.”

The Moderna vaccine is the mainstay of the booster campaign at present, and Germany also is using the BioNTech-Pfizer vaccine.

German officials hope that some who so far have been reluctant to get vaccinated will be persuaded to take the Novavax vaccine, made using an older technology and newly authorized by the European Medicines Agency. Lauterbach said Germany has bought 4 million doses of it and hopes to deploy them soon.

So far, 70.5% of Germany's population of 83 million has received a full first round of vaccination, a figure that officials — who had aimed for a minimum 75% — aren't satisfied with.

Meanwhile, 33.6% have received booster shots. That number is growing rapidly, with an average 1.1 million shots per day administered over the past week, the fastest pace of the pandemic so far.

___

Follow AP’s coverage of the coronavirus pandemic: https://apnews.com/hub/coronavirus-pandemic

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in